Christopher Durant Turner

Chief Medical Officer · 1 filing · Latest: Jul 15, 2026

Nuvalent, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
NUVL	Christopher Durant Turner	—	Jan 6, 2026	Proposed Sale	$97.58	7,417	$723.8K	—	Jan 6 1:55 AM
NUVL	Christopher Durant Turner	—	Jan 6, 2025	Proposed Sale	$80.78	4,250	$343.3K	—	Jan 6 11:01 AM